Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L39-like (RPL39L) is a protein-coding gene that encodes a protein highly similar to canonical ribosomal protein L39. RPL39L is primarily a male germ cell-specific component of the ribosome and is essential for sperm formation and male fertility; it replaces its paralog RPL39 in the ribosome of male germ cells[1][7]. The ribosomes containing RPL39L have a distinct polypeptide exit tunnel, influencing the translation and folding of male germ-cell-specific proteins[7]. Although classified as a ribosomal protein, it is currently unclear whether RPL39L can function independently of ribosomes[1][3]. Diseases reportedly associated with RPL39L include lacrimal gland carcinoma and seborrheic infantile dermatitis[1]. There is no evidence currently that RPL39L is a direct therapeutic target, nor are there drugs known to interact with it[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L39-like (RPL39L).